Monitoring size and oligomeric-state distribution of therapeutic mAbs by NMR and DLS: Trastuzumab as a case study
2010 ◽
Vol 24
(24)
◽
pp. 3510-3514
◽
Keyword(s):
Keyword(s):
1996 ◽
Vol 54
◽
pp. 636-637